Your browser doesn't support javascript.
loading
The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes.
Dong, Shen; Hiam-Galvez, Kamir J; Mowery, Cody T; Herold, Kevan C; Gitelman, Stephen E; Esensten, Jonathan H; Liu, Weihong; Lares, Angela P; Leinbach, Ashley S; Lee, Michael; Nguyen, Vinh; Tamaki, Stanley J; Tamaki, Whitney; Tamaki, Courtney M; Mehdizadeh, Morvarid; Putnam, Amy L; Spitzer, Matthew H; Ye, Chun Jimmie; Tang, Qizhi; Bluestone, Jeffrey A.
Afiliação
  • Dong S; Sean N. Parker Autoimmune Research Laboratory and.
  • Hiam-Galvez KJ; Diabetes Center, UCSF, San Francisco, California, USA.
  • Mowery CT; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.
  • Herold KC; Department of Microbiology and Immunology.
  • Gitelman SE; Biomedical Sciences Graduate Program.
  • Esensten JH; Department of Otolaryngology.
  • Liu W; Department of Microbiology and Immunology, and.
  • Lares AP; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, USA.
  • Leinbach AS; Chan Zuckerberg Biohub, San Francisco, California, USA.
  • Lee M; Institute for Human Genetics and.
  • Nguyen V; Medical Scientist Training Program, UCSF, San Francisco, California, USA.
  • Tamaki SJ; Department of Immunobiology and Internal Medicine, Yale University, New Haven, Connecticut, USA.
  • Tamaki W; Diabetes Center, UCSF, San Francisco, California, USA.
  • Tamaki CM; Division of Pediatric Endocrinology, Department of Pediatrics.
  • Mehdizadeh M; Department of Laboratory Medicine.
  • Putnam AL; Sean N. Parker Autoimmune Research Laboratory and.
  • Spitzer MH; Diabetes Center, UCSF, San Francisco, California, USA.
  • Ye CJ; Sean N. Parker Autoimmune Research Laboratory and.
  • Tang Q; Diabetes Center, UCSF, San Francisco, California, USA.
  • Bluestone JA; Sean N. Parker Autoimmune Research Laboratory and.
JCI Insight ; 6(18)2021 09 22.
Article em En | MEDLINE | ID: mdl-34324441

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Interleucina-2 / Linfócitos T Reguladores / Diabetes Mellitus Tipo 1 Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Revista: JCI Insight Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Interleucina-2 / Linfócitos T Reguladores / Diabetes Mellitus Tipo 1 Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Revista: JCI Insight Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos